Enovix (NASDAQ:ENVX) Releases Q1 2025 Earnings Guidance

Enovix (NASDAQ:ENVX) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of -0.210–0.150 for the period, compared to the consensus estimate of -0.170. The company issued revenue guidance of $3.5 million-$5.5 million, compared to the consensus revenue estimate of $6.2 million.

Enovix Price Performance

Shares of NASDAQ ENVX traded down $0.09 during mid-day trading on Friday, reaching $11.39. The company’s stock had a trading volume of 4,212,397 shares, compared to its average volume of 6,974,719. The firm has a market capitalization of $2.03 billion, a PE ratio of -7.87 and a beta of 1.87. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. The stock has a fifty day moving average of $11.11 and a two-hundred day moving average of $10.30. Enovix has a 52 week low of $5.70 and a 52 week high of $18.68.

Enovix (NASDAQ:ENVX) last announced its quarterly earnings results on Wednesday, February 19th. The company reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.01. Enovix had a negative return on equity of 96.99% and a negative net margin of 963.17%. The company had revenue of $9.72 million during the quarter, compared to analyst estimates of $8.77 million. As a group, sell-side analysts anticipate that Enovix will post -1.01 EPS for the current fiscal year.

Analysts Set New Price Targets

ENVX has been the subject of a number of research reports. Janney Montgomery Scott lowered Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target for the company. in a research note on Thursday, October 31st. Craig Hallum dropped their price target on Enovix from $20.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday. Cantor Fitzgerald restated an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research report on Thursday. Finally, Benchmark restated a “buy” rating and set a $25.00 price objective on shares of Enovix in a research report on Wednesday, October 30th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $20.30.

Insider Transactions at Enovix

In other news, Director Betsy S. Atkins sold 75,000 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total value of $729,750.00. Following the sale, the director now directly owns 99,497 shares in the company, valued at approximately $968,105.81. This represents a 42.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Company insiders own 15.70% of the company’s stock.

Enovix Company Profile

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.